Organon Opens REMS Program for MIUDELLA® Ahead of Anticipated Commercial Availability
Business Wire•11/08/2026•07:30 ET
0
Whiz Insights
Organon Opens REMS Program for MIUDELLA(®) Ahead of Anticipated Commercial Availability
Healthcare Providers, Healthcare Settings, and Participating Pharmacies Can Now Begin Required Training and Certification in Preparation for MIUDELLA’s Launch Later This Year
Get started
Create a free account to read the full story.